Text Size

Reproducibility of Computed Tomography

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Juliana Flávia de Oliveira, Federal University of Rio de Janeiro
ClinicalTrials.gov Identifier:
NCT01616264
First received: June 7, 2012
Last updated: June 8, 2012
Last verified: June 2012
History of Changes
  Purpose

Thus, the aim of this study was to evaluate the reproducibility of the Computed Tomograph scan three-dimensional reconstruction method for the measurement of the TB pleural effusion volume in clinically stable patients.


Condition
Tuberculosis
Pleural Effusion

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Evaluation of the Reproducibility of Computed Tomography for the Measurement of Tuberculosis Pleural Effusion

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Federal University of Rio de Janeiro:

Enrollment: 20
Study Start Date: January 2006
Study Completion Date: December 2009
Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)
Detailed Description:

Speed, accuracy, and precision in the quantification of pleural effusion are of critical importance as it determines whether or not thoracocentesis should be carried out and which technique should be employed for such a procedure. This study evaluates the precision of thoracic computed tomography with three-dimensional (3D) rebuilding in determining the volume of tuberculosis pleural effusion.Twenty patients with pleural effusion were screened and invited to take part in the study. Each patient underwent two computed tomography scans, before and after one month of treatment for tuberculosis, a total of 40 exams. These were evaluated by two expert radiologists. In conclusion, the quantification of the pleural effusion volume by using thoracic CT with volumetric three-dimensional reconstruction is a highly reproducible method.

  Eligibility

Ages Eligible for Study:   20 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients age 18 years or older with a confirmed diagnosis of pleural TB effusion

Criteria

Inclusion Criteria:

  • Patients age 18 years with a confirmed diagnosis of pleural TB effusion .
  • Signed out an informed consent term

Exclusion Criteria:

  • Patients with human immunodeficiency virus (HIV).
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01616264

Sponsors and Collaborators
Federal University of Rio de Janeiro
Investigators
Principal Investigator: Juliana F Oliveira, Phd Federal University of Rio de Janeiro
  More Information

No publications provided

Responsible Party: Juliana Flávia de Oliveira, Phd, Federal University of Rio de Janeiro
ClinicalTrials.gov Identifier: NCT01616264     History of Changes
Other Study ID Numbers: JUL 200456
Study First Received: June 7, 2012
Last Updated: June 8, 2012
Health Authority: Brazil: Ministry of Health

Keywords provided by Federal University of Rio de Janeiro:
Tuberculosis
Pleural Effusion
Computed Tomography

Additional relevant MeSH terms:
Pleural Effusion
Tuberculosis
Pleural Diseases
Respiratory Tract Diseases
 Mycobacterium Infections
Actinomycetales Infections
Gram-Positive Bacterial Infections
Bacterial Infections

ClinicalTrials.gov processed this record on May 16, 2013